Mitochondrial mutant cells are hypersensitive to ionizing radiation, phleomycin and mitomycin C

Rohan Kulkarni1, Adrian Reither, Robert A Thomas

  • 1Department of Biological Sciences, Wayne State University, Detroit, MI 48202, USA.

Mutation Research
|May 12, 2009
PubMed

Insights

Mitochondrial DNA mutations in Leber

Area of Science:

  • Mitochondrial genetics and cellular biology
  • DNA repair mechanisms and genotoxicity
  • Neurodegenerative disease pathogenesis

Background:

  • Mitochondrial DNA (mtDNA) mutations disrupt ATP production, leading to diseases like Leber optic atrophy and Leigh's syndrome.
  • Energy deprivation from mtDNA mutations may impair cellular responses to DNA damage.
  • Understanding these cellular responses is crucial for disease progression and therapeutic strategies.

Purpose of the Study:

  • To investigate the impact of Leber's and Leigh's syndrome-associated mtDNA mutations on nuclear DNA repair processes.
  • To determine if cells with mitochondrial mutations exhibit hypersensitivity to genotoxic stress.
  • To explore the role of ATP generation in cellular resistance to DNA damage.

Main Methods:

  • Induction of chromosomal aberrations in Leber's and Leigh's cells using ionizing radiation, phleomycin, and mitomycin C (MMC).
  • Comparison of DNA damage levels, mitotic indices, and cell death in mutant cells versus normal cells with wild-type mtDNA.
  • Assessment of cellular responses to oxidative and genotoxic stress.

Main Results:

  • Mitochondrial mutant cells showed increased chromosomal aberrations and decreased mitotic indices after radiation exposure compared to normal cells.
  • Cells with Leber's and Leigh's syndrome mutations exhibited hypersensitivity and reduced mitotic indices when exposed to phleomycin or MMC.
  • These findings indicate an impaired ability of mitochondrial mutant cells to cope with genotoxic stress.

Conclusions:

  • Leber's and Leigh's cells demonstrate impaired DNA repair and hypersensitivity to genotoxic stress, likely due to energy deprivation.
  • ATP generation is critical for cellular defense against DNA damage and environmental toxins.
  • Individuals with mtDNA mutations may face increased risks for cancers and other diseases linked to accumulated DNA damage.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...